# A Phase I Dose-finding Trial of Hyperthermic Intraperitoneal Paclitaxel Combined With Cisplatin

> **NCT05620654** · PHASE1 · UNKNOWN · sponsor: **Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University** · enrollment: 30 (estimated)

## Conditions studied

- Ovarian Cancer
- Hyperthermic Intraperitoneal Chemotherapy
- Paclitaxel

## Interventions

- **DRUG:** Hyperthermic Intraperitoneal Paclitaxel Combined With Cisplatin

## Key facts

- **NCT ID:** NCT05620654
- **Lead sponsor:** Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-01
- **Primary completion:** 2023-05-01
- **Final completion:** 2023-05-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05620654

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05620654, "A Phase I Dose-finding Trial of Hyperthermic Intraperitoneal Paclitaxel Combined With Cisplatin". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05620654. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*